News Focus
News Focus
Replies to #61604 on Biotech Values
icon url

DewDiligence

04/18/08 3:18 PM

#61607 RE: ghmm #61604

>Crestor – By chance would you know what the economics are for Shionogi (Is it a straight royalty/capped/etc.)?<

It’s unusual for Big Pharma to allow this kind of information to be disclosed, so the chances are it hasn’t been.

>My interest in Shionogi is for another drug not yet approved<

Pirfenidone, perchance? :-)
icon url

DewDiligence

04/24/08 8:15 AM

#61801 RE: ghmm #61604

1Q08 Crestor sales: $772M, +16%. Not bad, but it still has a long way to go to become the biggest-selling drug of all time.

http://www.astrazeneca.com/sites/7/imagebank/typearticleparam511817/astrazeneca-q1-results-2008-narrative.pdf

Crestor’s share of US Rx’s in the statin group was 8.5% in March 2008.